What Researchers Did
Researchers compared the in vitro susceptibility of 13 Scedosporium strains to various antifungal drugs under aerobic versus hyperbaric hyperoxic conditions.
What They Found
All 13 Scedosporium apiospermum and S. prolificans strains exhibited no growth after incubation in a hyperbaric hyperoxic atmosphere. However, growth systematically resumed within 36 to 96 hours when plates were returned to aerobic conditions, with minimal inhibitory concentration values remaining unchanged, indicating a fungistatic effect.
What This Means for Canadian Patients
This preliminary in vitro research suggests that hyperbaric oxygen therapy could potentially serve as an adjunct to antifungal treatments for Scedosporium infections. This approach might enhance the effectiveness of existing drugs, offering a new strategy for managing these often multi-drug resistant infections.
Canadian Relevance
This study has no direct Canadian connection.
Study Limitations
A key limitation is that this was a preliminary in vitro study, so its findings may not directly translate to clinical outcomes in patients.